Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmiva AB (publ)
AB
Dissolved
Org 5590070958
Other research and experimental development on natural sciences and engineering
·
NACE 7219
Est. 2015 · 11 years old
7 employees
Monitor
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
Pharmiva AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2019: 0M
0M
2019
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 3M
3M
2022
EBITDA
SEK millions
0M
-7M
-14M
-21M
-27M
2019: -4M
-4M
2019
2019: -7M (-75% vs 2019)
-7M
-75%
2019
2020: -13M (-86% vs 2019)
-13M
-86%
2020
2021: -20M (-54% vs 2020)
-20M
-54%
2021
2022: -22M (-10% vs 2021)
-22M
-10%
2022
Income statement
SEK thousands
Item
2022
2021
2020
2019
2019
Revenue
2 628
248
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−22 268
−19 602
−13 292
−6 584
−3 724
Depreciation & amort.
−1 400
−1 160
−666
−780
−0
EBIT
−23 668
−20 762
−13 958
−7 364
−3 724
Net financials
−4
−1
−48
−46
−170
Profit before tax
−23 672
−20 763
−14 006
−7 410
−3 894
Tax
−0
−0
−0
−0
−0
Net profit
−23 672
−20 763
−14 006
−7 410
−3 894
Balance sheet
SEK thousands
Item
2022
2021
2020
2019
2019
Total assets
30 060
33 752
23 695
18 785
26 145
Equity
26 835
30 827
20 754
14 842
23 625
Long-term debt
0
0
0
405
0
Short-term debt
3 225
2 925
2 941
3 538
2 520
Total debt
3 225
2 925
2 941
3 943
2 520
Financial ratios
5-year trend
EBITDA margin
−847,3 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2019
2022
Equity ratio
89,3 %
This company
38,2 %
Market median
This company
Market median
134% above market
2019
2022
Return on equity
−88,2 %
This company
18,4 %
Market median
This company
Market median
579% below market
2019
2022
Net profit margin
−900,8 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2019
2022
Asset turnover
0,09×
This company
1,12×
Market median
This company
Market median
92% below market
2019
2022
Debt / equity
0,12×
This company
0,62×
Market median
This company
Market median
81% below market
2019
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-05-01 – 2019-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
View
PDF
More on Pharmiva AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
